Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Lance Okeke

HIV/AIDS Medicine · Duke University

View

Dr. Raphael J. Landovitz

HIV/AIDS Medicine · UCLA

View

Dr. Aniruddha Hazra

HIV/AIDS Medicine · UCMC

View

Dr. Shital Patel

HIV/AIDS Medicine · BCM

View

Dr. Monica Gandhi

HIV/AIDS Medicine · UCSF

View

Dr. Ashwin Balagopal

HIV/AIDS Medicine · Johns Hopkins

View

Dr. Ofole Mgbako

HIV/AIDS Medicine · NYU Langone

View

Dr. Joshua Barocas

HIV/AIDS Medicine · CU Anschutz Medical Campus

View

Dr. Chris Beyrer

Global Health · Duke University

View

Dr. Keith Kaye

General ID · RU

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts

    May 14, 2026DOI: 10.1056/nejmoa2509306Original ArticleNEJM

    Written by: Frederick G. Hayden, M.D.Masaharu Shinkai, M.D., Ph.D.Tristan W. Clark, M.D.Anne F. Luetkemeyer, M.D.Paul E. Sax, M.D.William P. Hanage, Ph.D.Kelly A. Gebo, M.D., M.P.H.Hideyuki Ikematsu, M.D.Koichi Izumikawa, M.D., Ph.D.Akimasa Fukushi, M.S.Safwan Kezbor, M.D.Hiroki Sakaguchi, Ph.D.Stuart Lacey, M.Sc.Genki Ichihashi, M.S.Norio Ohmagari, M.D., Ph.D.Takeki Uehara, Ph.D.

    Find these authors on Roon

    KG
    Dr. Kelly Gebo
    HIV/AIDS Medicine · GW
    [Free Article]

    Summary

    In a trial, the 3C-like protease inhibitor ensitrelvir was more effective than placebo in preventing Covid-19 in household contacts of patients with SARS-CoV-2 infection.
    KGDr. Kelly Gebo

    Dr. Kelly Gebo

    Infectious Disease · HIV & AIDS Medicine
    George Washington University
    kellyg